Pliant Therapeutics Inc (PLRX) Stock Price, Quote & News

Company Profile

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonal...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 481 6770

Website: pliantrx.com

Address:

331 Oyster Point Boulevard, South San Francisco, United States

DirtyUnicorn Jun. 12 at 2:46 PM

$PLRX stick

0 · Reply

gaarainthehood Jun. 9 at 1:40 PM

$PLRX ultimamente continua a salire, se rompe 1.70 potremmo confermare il

0 · Reply

Webullbro Jun. 4 at 10:09 PM

$PLRX any news in this one here it explodes

1 · Reply

Webullbro Jun. 3 at 3:13 PM

$PLRX on watch

0 · Reply

Bellbent Jun. 3 at 3:01 PM

$PLRX shorts are just starting to cover from the massive sell off here, news is coming. I had a great conversation with CEO.

0 · Reply

Bellbent Jun. 3 at 2:16 PM

$LYRA $PLRX Pliant Therapeutics is drastically oversold with their latest 85% selloff which turned out as of last week to be GOOD data! Hugely cash rich!

0 · Reply

Bellbent Jun. 3 at 2:02 PM

$PLRX

0 · Reply

Drugtrade Jun. 3 at 10:36 AM

$PLRX after Lyra im on the lookout for beaten down cash plays to park my money. Patience is fundamental key

0 · Reply

nUme22 Jun. 3 at 9:08 AM

$PLRX I think bottom is in … buying here could give 2-3x easily.. Ala $LYRA

0 · Reply

Bellbent Jun. 2 at 5:17 PM

$PLRX hoping for 3+ this month, way too cheap.

0 · Reply

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

May 8, 2025, 4:05 PM EDT - 5 weeks ago

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 1, 2025, 4:05 PM EDT - 6 weeks ago

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Apr 7, 2025, 4:05 PM EDT - 2 months ago

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

Apr 3, 2025, 12:22 PM EDT - 2 months ago

Pliant Therapeutics: An Activist On Deck

$Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors$

Mar 17, 2025, 8:00 AM EDT - 3 months ago

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Mar 13, 2025, 11:04 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 13, 2025, 7:20 AM EDT - 3 months ago

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

Mar 3, 2025, 4:05 PM EST - 3 months ago

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Mar 3, 2025, 1:32 PM EST - 3 months ago

Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder

Mar 3, 2025, 9:27 AM EST - 3 months ago

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Mar 2, 2025, 11:00 AM EST - 3 months ago

The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation

Feb 27, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Shareholders to Inquire about Securities Investigation

Feb 26, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Connect

Feb 25, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Reach Out

Feb 24, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Shareholders to Learn More About the Investigation

Feb 23, 2025, 10:00 AM EST - 4 months ago

Pliant Therapeutics, Inc. (PLRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Connect

Feb 20, 2025, 3:39 PM EST - 4 months ago

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Feb 20, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Stockholders to Inquire about Securities Investigation

Feb 19, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Investors to Learn More About the Investigation

Feb 18, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Stockholders to Learn More About the Investigation

Feb 17, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Investors to Inquire about Securities Investigation

Feb 16, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Reach Out

Feb 14, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Stockholders to Reach Out

DirtyUnicorn Jun. 12 at 2:46 PM

$PLRX stick

0 · Reply

gaarainthehood Jun. 9 at 1:40 PM

$PLRX ultimamente continua a salire, se rompe 1.70 potremmo confermare il

0 · Reply

Webullbro Jun. 4 at 10:09 PM

$PLRX any news in this one here it explodes

1 · Reply

Webullbro Jun. 3 at 3:13 PM

$PLRX on watch

0 · Reply

Bellbent Jun. 3 at 3:01 PM

$PLRX shorts are just starting to cover from the massive sell off here, news is coming. I had a great conversation with CEO.

0 · Reply

Bellbent Jun. 3 at 2:16 PM

$LYRA $PLRX Pliant Therapeutics is drastically oversold with their latest 85% selloff which turned out as of last week to be GOOD data! Hugely cash rich!

0 · Reply

Bellbent Jun. 3 at 2:02 PM

$PLRX

0 · Reply

Drugtrade Jun. 3 at 10:36 AM

$PLRX after Lyra im on the lookout for beaten down cash plays to park my money. Patience is fundamental key

0 · Reply

nUme22 Jun. 3 at 9:08 AM

$PLRX I think bottom is in … buying here could give 2-3x easily.. Ala $LYRA

0 · Reply

Bellbent Jun. 2 at 5:17 PM

$PLRX hoping for 3+ this month, way too cheap.

0 · Reply

Bellbent May. 30 at 5:03 PM

$PLRX waiting for insider buying updates soon. Spoke to CEO he is a buyer.

0 · Reply

ka1954 May. 30 at 4:26 PM

$PLRX for someone following this stock, why were there 2 big drops earlier this year

1 · Reply

Webullbro May. 29 at 1:01 PM

$PLRX

0 · Reply

Rvazstocksfl May. 28 at 3:09 PM

$PLRX 50 cents eod

0 · Reply

jasonlin280 May. 28 at 1:12 AM

$PLRX 300mil in cash, capable to pay down the total debt and it will take us to the next lv

0 · Reply

Bellbent May. 23 at 8:03 PM

$PLRX https://www.stocktitan.net/news/PLRX/pliant-therapeutics-presents-clinical-and-preclinical-data-at-the-0f8651a2h3ti.html

0 · Reply

Bellbent May. 22 at 6:25 PM

$PLRX partnership news eminent, data looks great in a combo. Still a great pipeline and lots more cost saving to do, bonds paying well with a large cash pile, time is on our side! @BioGem

0 · Reply

Webullbro May. 22 at 10:15 AM

$PLRX Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

0 · Reply

Bellbent May. 21 at 10:46 PM

$PLRX lots of volume here ah, with news! https://www.globenewswire.com/news-release/2025/05/21/3086144/0/en/Pliant-Therapeutics-Presents-Clinical-and-Preclinical-Data-at-the-American-Thoracic-Society-International-Conference.html

4 · Reply

notmymoney May. 21 at 11:28 AM

$WOLF 99% sure it will be full nice round number $2 down. Not so sure what comes after $1.13 though. Could go under a buck and the way this market has been reacting to share dilutions such as $NCNA $PLRX $HCTI a big flush? I will just try selling some $.5 puts

1 · Reply

Bellbent May. 20 at 12:32 AM

$PLRX waiting for c suite to load and news to come shorty after!

0 · Reply

Webullbro May. 19 at 12:43 PM

$PLRX premium turd

0 · Reply

Market Cap	84.71M
Revenue (ttm)	0.00
Net Income (ttm)	-210.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	561,200
Avg Vol	951,616
Day's Range	N/A - N/A
Shares Out	61.39M
Stochastic %K	6%
Beta	1.35
Analysts	Sell
Price Target	$4.79